Kura Oncology KURA Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $149.1M-33.6% | $224.46M+501% | $37.32M-28.0% | $51.8M-42.9% | ||
| $518.14M+3.0% | $502.93M+30.1% | $386.64M+0.1% | $386.18M-9.6% | ||
| $8.8M+327% | $2.06M— | $0— | —— | ||
| $722.75K— | $0— | $0— | —— | ||
| $708.66M-4.9% | $744.83M+72.2% | $432.48M-3.1% | $446.43M-14.5% | ||
| $7.86M+367% | $1.68M-9.5% | $1.86M-26.8% | $2.54M-5.0% | ||
| $738.36M-2.9% | $760.16M+69.3% | $448.94M-1.6% | $456.31M-14.6% | ||
| $5.02M+242% | $1.47M-95.6% | $33.76M+55.3% | $21.74M+572% | ||
| $48.98M+102% | $24.27M— | —— | —— | ||
| $0-100% | $2.61M— | —— | —— | ||
| $116.97M+48.6% | $78.71M+123% | $35.26M+46.6% | $24.06M+7.1% | ||
| $9.71M+40.4% | $6.92M-25.9% | $9.33M+1.9% | $9.16M— | ||
| $564.23M+62.8% | $346.52M+571% | $51.66M+43.4% | $36.03M+31.3% | ||
| $9K+12.5% | $8K+14.3% | $7K0.0% | $7K0.0% | ||
| -$1.17B-31.1% | -$895.42M-24.1% | -$721.44M-26.8% | -$568.81M-31.4% | ||
| $174.14M-57.9% | $413.64M+4.1% | $397.27M-5.5% | $420.28M-17.0% | ||
| $738.36M-2.9% | $760.16M+69.3% | $448.94M-1.6% | $456.31M-14.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Kura Oncology's total assets?
- Kura Oncology (KURA) holds $652.6M in total assets, down 12.3% year over year.
- How much debt does Kura Oncology have?
- Kura Oncology carries $24.3M in total debt against $107.9M of shareholders' equity, a debt-to-equity ratio of 0.23.
- How much cash does Kura Oncology have?
- Kura Oncology holds $39.1M in cash and equivalents.
- Can Kura Oncology cover its short-term obligations?
- Its current ratio is 6.15 — current assets exceed current liabilities.
- Where does Kura Oncology's balance sheet data come from?
- Every line is extracted from Kura Oncology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
